Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (SHA:605016)
26.29
-0.42 (-1.57%)
Apr 17, 2026, 3:00 PM CST
SHA:605016 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 501.7 | 286.84 | 175.87 | 191.69 | 305.24 |
Trading Asset Securities | 20.09 | 152.27 | 252.7 | 330 | 248.35 |
Cash & Short-Term Investments | 521.8 | 439.11 | 428.57 | 521.69 | 553.59 |
Cash Growth | 18.83% | 2.46% | -17.85% | -5.76% | 291.63% |
Accounts Receivable | 295.18 | 231.44 | 169.43 | 152.63 | 143.62 |
Other Receivables | 16.37 | 9.46 | 4.85 | 2.21 | 1.45 |
Receivables | 311.55 | 240.9 | 174.27 | 154.83 | 145.07 |
Inventory | 287.39 | 186.83 | 152.05 | 167.71 | 121.82 |
Prepaid Expenses | - | 0.62 | 0 | 0.11 | - |
Other Current Assets | 14.43 | 34 | 18.84 | 11.19 | 11.41 |
Total Current Assets | 1,135 | 901.46 | 773.74 | 855.54 | 831.89 |
Property, Plant & Equipment | 1,178 | 987.82 | 854.02 | 500.99 | 370.5 |
Long-Term Investments | 61.95 | 60.88 | 58.98 | 58.9 | 57.17 |
Other Intangible Assets | 16.35 | 17.58 | 14.19 | 14.74 | 15.31 |
Long-Term Deferred Tax Assets | 7.83 | 6.74 | 2.39 | 2.58 | 2.57 |
Long-Term Deferred Charges | 14.65 | 12.14 | 2.42 | 1.23 | 1.78 |
Other Long-Term Assets | 22.94 | 26.88 | 48.45 | 37.96 | 3.29 |
Total Assets | 2,437 | 2,014 | 1,754 | 1,472 | 1,283 |
Accounts Payable | 169.39 | 242.81 | 214.89 | 93.34 | 46.05 |
Accrued Expenses | 11.17 | 27.88 | 15.83 | 17.11 | 13.49 |
Short-Term Debt | 138.99 | 10 | - | - | 1 |
Current Portion of Long-Term Debt | 6.2 | - | - | - | - |
Current Portion of Leases | - | 1.18 | 1.03 | 1.1 | 0.74 |
Current Income Taxes Payable | 21.11 | 16.54 | 6.9 | 5.33 | 2.9 |
Current Unearned Revenue | 4.52 | 3.51 | 2.89 | 4.07 | 6.89 |
Other Current Liabilities | 12.4 | 0.53 | 0.15 | 0.15 | 0.15 |
Total Current Liabilities | 363.78 | 302.45 | 241.7 | 121.11 | 71.21 |
Long-Term Debt | 79.06 | - | - | - | - |
Long-Term Leases | 0.94 | 1.02 | 0.63 | 0.35 | 0.78 |
Long-Term Unearned Revenue | 28.35 | 27.92 | 1.41 | 2.97 | 4.76 |
Long-Term Deferred Tax Liabilities | 3.06 | 2.89 | 2.62 | 2.58 | 2.31 |
Total Liabilities | 475.19 | 334.27 | 246.35 | 127.01 | 79.05 |
Common Stock | 420.01 | 323.09 | 248.53 | 177.52 | 126.8 |
Additional Paid-In Capital | 337.31 | 434.23 | 508.79 | 579.8 | 630.52 |
Retained Earnings | 1,187 | 905.7 | 735.91 | 573.09 | 433.08 |
Comprehensive Income & Other | 17.13 | 16.22 | 14.6 | 14.54 | 13.06 |
Shareholders' Equity | 1,961 | 1,679 | 1,508 | 1,345 | 1,203 |
Total Liabilities & Equity | 2,437 | 2,014 | 1,754 | 1,472 | 1,283 |
Total Debt | 225.2 | 12.2 | 1.66 | 1.45 | 2.52 |
Net Cash (Debt) | 296.59 | 426.91 | 426.91 | 520.24 | 551.07 |
Net Cash Growth | -30.53% | -0.00% | -17.94% | -5.59% | 656.39% |
Net Cash Per Share | 0.71 | 1.02 | 1.02 | 1.25 | 1.43 |
Filing Date Shares Outstanding | 420.01 | 420.01 | 420.01 | 420.01 | 420.01 |
Total Common Shares Outstanding | 420.01 | 420.01 | 420.01 | 420.01 | 420.01 |
Working Capital | 771.38 | 599.01 | 532.04 | 734.43 | 760.68 |
Book Value Per Share | 4.67 | 4.00 | 3.59 | 3.20 | 2.87 |
Tangible Book Value | 1,945 | 1,662 | 1,494 | 1,330 | 1,188 |
Tangible Book Value Per Share | 4.63 | 3.96 | 3.56 | 3.17 | 2.83 |
Land | - | 34.94 | - | - | - |
Buildings | - | 477.49 | 180.6 | 158.6 | 162.18 |
Machinery | - | 820.77 | 433.86 | 417.39 | 415.03 |
Construction In Progress | - | 10.29 | 522.23 | 193.36 | 17.12 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.